Research Article

Prevalence and Predictive Factors of Early Degeneration of Bioprosthetic Mitral Valves: A Single-Center Cohort Study

Table 4

Follow-up echocardiographic characteristics of the study population and comparison between patients with and without bioprosthetic mitral valve early degeneration.

Follow-up echo characteristicTotal (n = 177)Normal (n = 138)Degeneration (n = 39) value

Years between surgery and last echo, year2.1 ± 0.72.1 ± 1.72.2 ± 0.80.55
Patient-prosthesis mismatch, n (%)77 (43.5)58 (43.3)19 (48.7)0.55
Mitral valve peak gradient11.9 ± 3.811.5 ± 3.513.2 ± 4.50.01
Mitral valve mean gradient5.1 ± 1.74.78 ± 1.506.38 ± 1.800.01

Paravalvular leak, n (%)0.03
None170 (96.0)135 (97.8)35 (89.7)
Trivial2 (1.1)2 (1.4)0 (0)
Mild2 (1.1)1 (0.7)1 (2.6)
Mild to moderate1 (0.6)0 (0)1 (2.6)
Moderate1 (0.6)0 (0)1 (2.6)
Severe1 (0.6)0 (0)1 (2.6)

Transvalvular mitral regurgitation, n (%)0.01
None64 (35.6)53 (38.4)10 (25.6)
Trivial24 (13.6)20 (14.5)4 (10.3)
Mild74 (41.8)65 (47.1)10 (25.6)
Mild to moderate9 (5.1)0 (0)9 (23.1)
Moderate3 (1.7)0 (0)3 (7.7)
Moderate to severe2 (1.1)0 (0)2 (5.1)
Severe1 (0.6)0 (0)1 (2.6)

PAP33.8 ± 10.533.2 ± 10.635.2 ± 9.90.33
LVES dimension, mm35.2 ± 7.434.4 ± 7.237.7 ± 7.40.01
LVED dimension, mm50.1 ± 6.549.4 ± 6.352.6 ± 6.60.01
Left atrial size47.3 ± 8.546.5 ± 8.050.4 ± 9.70.01
Mitral valve area index1.19 ± 0.251.19 ± 0.251.20 ± 0.220.78
Effective orifice area2.13 ± 1.612.17 ± 1.842.01 ± 0.340.62
Last peak e velocity1.59 ± 0.311.57 ± 0.321.66 ± 0.260.25
PHT100.6 ± 36.996.6 ± 31.3114.4 ± 49.80.05
Doppler velocity index2.19 ± 0.612.10 ± 0.442.49 ± 0.930.02

Right ventricular dysfunction, n (%)0.44
None25 (14.1)21 (15.2)4 (10.3)
Mild109 (61.6)81 (58.7)28 (71.8)
Moderate40 (22.6)33 (23.9)7 (17.9)
Severe3 (1.7)3 (2.2)0 (0)
Left atrial dilation, n (%)0.07
None18 (10.2)17 (12.3)1 (2.6)
Mild55 (3.1.1)45 (32.6)10 (25.6)
Moderate49 (27.7)39 (28.3)10 (25.6)
Severe55 (31.1)37 (26.8)18 (46.2)

was considered statistically significant. LVED: left ventricular end-diastolic; LVES: left ventricular end-systolic; PAP: pulmonary arterial pressure; PHT: pressure half-time.